Aprea Therapeutics Inc.

NASDAQ: APRE · Real-Time Price · USD
1.90
-0.02 (-1.04%)
At close: Jun 13, 2025, 3:58 PM
1.80
-5.26%
After-hours: Jun 13, 2025, 06:59 PM EDT

Aprea Therapeutics Statistics

Share Statistics

Aprea Therapeutics has 5.53M shares outstanding. The number of shares has increased by 1.14% in one year.

5.53M
1.14%
1.05%
37.7%
4.83M
753
2.75%

Short Selling Information

The latest short interest is 73.65K, so 1.33% of the outstanding shares have been sold short.

73.65K
1.33%
1.51%
2.1

Valuation Ratios

The PE ratio is -1.4 and the forward PE ratio is -1.32. Aprea Therapeutics's PEG ratio is 0.03.

-1.4
-1.32
12.06
0.1
0.94
-1.34
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Aprea Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.

7.01
7.01
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$187,822.62
$-1,619,838.88
8
0.06
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -56.92% in the last 52 weeks. The beta is 1.61, so Aprea Therapeutics's price volatility has been higher than the market average.

1.61
-56.92%
1.7
2.83
52.86
27,390

Income Statement

In the last 12 months, Aprea Therapeutics had revenue of 1.5M and earned -12.96M in profits. Earnings per share was -2.35.

1.5M
1.48M
-14.32M
-12.96M
-12.94M
-12.96M
-2.35
Full Income Statement

Balance Sheet

The company has 22.85M in cash and 0 in debt, giving a net cash position of 22.85M.

22.85M
n/a
n/a
-321.04M
20.22M
16.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.56M and capital expenditures -15.48K, giving a free cash flow of -13.57M.

-13.56M
-15.48K
-13.57M
-2.46
Full Cash Flow Statement

Margins

Gross margin is 98.51%, with operating and profit margins of -953% and -862.43%.

98.51%
-953%
-862.43%
-862.43%
-860.94%
-953%
-903.26%

Dividends & Yields

APRE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for APRE is $15.5, which is 715.8% higher than the current price. The consensus rating is "Buy".

$15.5
715.8%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Feb 13, 2023. It was a backward split with a ratio of 1:20.

Feb 13, 2023
backward
1:20

Scores

-22.74
1